Clinical Study | Office of Clinical Research

A Study Of Oral Ziprasidone In Kids With Bipolar I Disorder

Posted Date: Jan 14, 2020

Investigator: Melissa Delbello
Specialties: Adolescent Psychiatry/Psychology, Bipolar Disorder, Psychiatry/Psychology
Type of Study: Drug

A PHASE 3, MULTICENTER, FOUR-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED, PARALLEL-GROUP EFFICACY AND SAFETY TRIAL OF FLEXIBLE DOSES OF ORAL ZIPRASIDONE IN CHILDREN AND ADOLESCENTS WITH BIPOLAR I DISORDER (CURRENT OR MOST RECENT EPISODE MANIC)

Criteria:

Youth, Ages 10-17, With Diagnosis Of Bipolar I Disorder Or Suspected To Have Bipolar Disorder.

Keywords:

Ziprasidone, Bipolar I Disorder, Manic

For More Information:

Kaitlyn Bruns
(513) 558-5303
brunskn@ucmail.uc.edu

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List